American Health Packaging Cyanocobalamin Injection Recall

Why it was recalled

Subpotent Drug: Out of specification for assay.

Product description

Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59

Lot numbers, UPCs & expiration codes

Lots: CCC210008, CCC210009, Exp. 01/23

Where it was sold

Alabama

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0790-2022
Classification: Class III
Status: Terminated
Recall initiated: Apr 12, 2022
FDA report date: May 4, 2022
Quantity: 97,975 vials
Recall type: Voluntary: Firm initiated
Recalling firm: American Health Packaging

Original FDA data

Every field from FDA enforcement report D-0790-2022, exactly as published.

Show all FDA fields

City: Columbus
State: OH
Status: Terminated
Country: United States
Event ID: 90003
Address: 2550 John Glenn Ave Ste A
Code information: Lots: CCC210008, CCC210009, Exp. 01/23
Postal code: 43217-1188
Report date: May 4, 2022
Product type: Drugs
Recall number: D-0790-2022
Classification: Class III
Recalling firm: American Health Packaging
Product quantity: 97,975 vials
Termination date: Dec 28, 2022
Reason for recall: Subpotent Drug: Out of specification for assay.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59
Distribution pattern: Alabama
Recall initiation date: Apr 12, 2022
Initial firm notification: Letter
Center classification date: Apr 26, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0790-2022, published May 4, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.